GHRH/GHRP and GH equivalence.

SJB78

New Member
Hi guys,
This question is going to be a bit open ended and dose related and answers can vary. I have been researching HGH and at this point in my life I dont think I can run it for various reasons which include:
A) I cant afford it
B) I live in Australia and customs here are pretty full on and getting gear through them is too risky (I was looking at Pharmacom but I cant risk it)
C) No domestic source that I can trust (and Im not looking for one on here)
D) The only domestic source I know of is extremely expensive and not reliable

So because of this I have been researching the GHRH and GHRP peptides and I have a fantastic source who is domestic and is a legal anti ageing clinic that gets peptides from a compounding pharmacy on a doctors prescription (see www.peptideclinics.com.au) however it is very expensive. Peptides are legal in Australia as long as its from a doctor and you cant import or export.
What I have been particularly interested in is the CJC-1295/Ipamorelin combo which comes as 2000mcg/ml in a 5ml vial. The dosage protocol is to take 0.14ml 2-4 times per day. Im shit at maths so im not sure how many mcg this comes to.

So my question is what is this equivalent to in regards to exogenous growth hormone use? For example is using 0.14ml of this peptide combo the same as doing 4-5iu's of growth hormone daily?
I know its a very open question and may not be a simple answer. So in general is using these peptides going to release the same amount of HGH as injecting exogenous HGH?
 
That's impossible to estimate for a variety of reasons such as;

- PEP UGL quality differences

- HTPA receptor susceptibility

- the varying degree with which some PEPs cross the blood/brain barrier

- very short half life of PEPs

- limited ability of PEP to change (increase) IGF levels

- the influence one PEP may have on another with respect to HTPA receptor up/down regulation

I'm sure there are others!

Jim
 
That's impossible to estimate for a variety of reasons such as;

- PEP UGL quality differences

- HTPA receptor susceptibility

- the varying degree with which some PEPs cross the blood/brain barrier

- very short half life of PEPs

- limited ability of PEP to change (increase) IGF levels

- the influence one PEP may have on another with respect to HTPA receptor up/down regulation

I'm sure there are others!

Jim
I thought it would be a bit difficult to determine. Thanks though................
 
Back
Top